Effects of atropine and neostigmine on receptor interaction at the neuromuscular junction

Arch Int Pharmacodyn Ther. 1975 Oct;217(2):236-45.

Abstract

Rats treated chronically with atropine or atropine and neostigmine showed marked alterations in the responsiveness of receptors at the neuromuscular junction. Receptors in the phrenic nerve-hemidiaphragm interacting with d-tubocurarine were unaffected by atropine but exhibited a supersensitivity after neostigmine administration. Succinylcholine-sensitive sites developed a subsensitivity with both atropine and neostigmine treatment. Acetylcholine-induced contractures in the denervated hemidiaphragm showed a hypersensitivity after both drug administrations, but responses to carbamylcholine were unaffected. It is suggested that there exists a heterogeneous population of receptors at the mammalian neuromuscular junction who can be identified by their responses to the effects of chronic drug application.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Atropine / pharmacology*
  • Cholinesterases / metabolism
  • Denervation
  • Diaphragm / drug effects
  • Diaphragm / enzymology
  • Drug Interactions
  • Electric Stimulation
  • In Vitro Techniques
  • Male
  • Muscle Contraction / drug effects
  • Neostigmine / pharmacology*
  • Neuromuscular Junction / drug effects*
  • Phrenic Nerve / physiology
  • Rats
  • Receptors, Drug / drug effects
  • Succinylcholine / pharmacology
  • Tubocurarine / pharmacology

Substances

  • Receptors, Drug
  • Neostigmine
  • Atropine
  • Cholinesterases
  • Succinylcholine
  • Tubocurarine